These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25086653)

  • 1. Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine.
    Singhal R; Harrill AH; Menguy-Vacheron F; Jayyosi Z; Benzerdjeb H; Watkins PB
    BMC Pharmacol Toxicol; 2014 Aug; 15():42. PubMed ID: 25086653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience.
    Marcinak JF; Munsaka MS; Watkins PB; Ohira T; Smith N
    Drug Saf; 2018 Jun; 41(6):625-640. PubMed ID: 29492878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis.
    Genovese MC; Kremer JM; van Vollenhoven RF; Alten R; Scali JJ; Kelman A; Dimonaco S; Brockwell L
    Arthritis Rheumatol; 2017 Sep; 69(9):1751-1761. PubMed ID: 28597609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers.
    Harrill AH; Roach J; Fier I; Eaddy JS; Kurtz CL; Antoine DJ; Spencer DM; Kishimoto TK; Pisetsky DS; Park BK; Watkins PB
    Clin Pharmacol Ther; 2012 Aug; 92(2):214-20. PubMed ID: 22739141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of transient elevations in alanine aminotransferase during long-term treatment with acetaminophen in osteoarthritis clinical trials.
    Kuffner EK; Temple AR; Cooper KM; Baggish JS; Parenti DL
    Curr Med Res Opin; 2006 Nov; 22(11):2137-48. PubMed ID: 17076974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic Adaptation to Therapeutic Doses of Acetaminophen: An Exploratory Study in Healthy Individuals.
    Maeda M; Tanaka R; Aso M; Sakamoto Y; Song I; Ochiai M; Saito Y; Maekawa K; Arakawa N; Ohno Y; Kumagai Y
    Clin Ther; 2020 Jul; 42(7):1276-1291.e1. PubMed ID: 32620339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transformation in biomarker detection and management of drug-induced liver injury.
    Church RJ; Watkins PB
    Liver Int; 2017 Nov; 37(11):1582-1590. PubMed ID: 28386997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma.
    Watkins PB; Dube LM; Walton-Bowen K; Cameron CM; Kasten LE
    Drug Saf; 2007; 30(9):805-15. PubMed ID: 17722971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of miR-122 as a Serum Biomarker for Hepatotoxicity in Investigative Rat Toxicology Studies.
    Sharapova T; Devanarayan V; LeRoy B; Liguori MJ; Blomme E; Buck W; Maher J
    Vet Pathol; 2016 Jan; 53(1):211-21. PubMed ID: 26123229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The early effects of short-term dexamethasone administration on hepatic and serum alanine aminotransferase in the rat.
    Jackson ER; Kilroy C; Joslin DL; Schomaker SJ; Pruimboom-Brees I; Amacher DE
    Drug Chem Toxicol; 2008; 31(4):427-45. PubMed ID: 18850354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments.
    Schomaker S; Potter D; Warner R; Larkindale J; King N; Porter AC; Owens J; Tomlinson L; Sauer JM; Johnson K; Aubrecht J
    PLoS One; 2020; 15(5):e0229753. PubMed ID: 32407333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients.
    Stern JO; Robinson PA; Love J; Lanes S; Imperiale MS; Mayers DL
    J Acquir Immune Defic Syndr; 2003 Sep; 34 Suppl 1():S21-33. PubMed ID: 14562855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials.
    Church RJ; Watkins PB
    Exp Biol Med (Maywood); 2018 Feb; 243(3):300-307. PubMed ID: 29096561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non-alcoholic fatty liver disease.
    Shiffman M; Freilich B; Vuppalanchi R; Watt K; Chan JL; Spada A; Hagerty DT; Schiff E
    Aliment Pharmacol Ther; 2019 Jan; 49(1):64-73. PubMed ID: 30430605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubrogepant Is Not Associated With Clinically Meaningful Elevations of Alanine Aminotransferase in Healthy Adult Males.
    Ankrom W; Bondiskey P; Li CC; Palcza J; Liu W; Dockendorf MF; Matthews C; Panebianco D; Reynders T; Wagner JA; Jakate A; Mesens S; Kraft WK; Marcantonio EE
    Clin Transl Sci; 2020 May; 13(3):462-472. PubMed ID: 31899602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile Acid Sequestration by Cholestyramine Mitigates FGFR4 Inhibition-Induced ALT Elevation.
    Schadt HS; Wolf A; Mahl JA; Wuersch K; Couttet P; Schwald M; Fischer A; Lienard M; Emotte C; Teng CH; Skuba E; Richardson TA; Manenti L; Weiss A; Graus Porta D; Fairhurst RA; Kullak-Ublick GA; Chibout SD; Pognan F; Kluwe W; Kinyamu-Akunda J
    Toxicol Sci; 2018 May; 163(1):265-278. PubMed ID: 29432567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SERIAL CHANGES OF LIVER FUNCTION TESTS BEFORE AND DURING METHIMAZOLE TREATMENT IN THYROTOXIC PATIENTS.
    Niculescu DA; Dusceac R; Galoiu SA; Capatina CA; Poiana C
    Endocr Pract; 2016 Aug; 22(8):974-9. PubMed ID: 27042749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atogepant Is Not Associated With Clinically Meaningful Alanine Aminotransferase Elevations in Healthy Adults.
    Min KC; Kraft WK; Bondiskey P; Colón-González F; Liu W; Xu J; Panebianco D; Mixson L; Dockendorf MF; Matthews CZ; Boinpally R
    Clin Transl Sci; 2021 Mar; 14(2):599-605. PubMed ID: 33142014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining patient risks from expanded preventive therapies.
    Tolman KG
    Am J Cardiol; 2000 Jun; 85(12A):15E-9E. PubMed ID: 10858489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.